Multi-Disciplinary Approach for Diagnosis of Antibody Mediated Rejection (AMR) in Lung Transplant Recipients – A Guide
12 January, 2026 1:00 p.m. to 2:00 p.m. EST
A case presentation of antibody mediated rejection (AMR) in a lung transplant recipient. The multi-disciplinary approach is illustrated by the contribution of each expert, highlighting the specific nuances of each discipline: determination of donor-specific HLA antibody, the spectrum of histopathological changes, graft dysfunction, and the incorporation of non-invasive biomarkers to facilitate early detection of AMR and to monitor response to treatment. At the end of this session, the panel of experts will be available for discussion and questions from the participants.
Moderators
Adriana Zeevi, PhD
Ramsey Hachem, MD
Presentations
Pulmonology: Clinical Presentation and Management
Presented by Ramsey Hachem, MD
Histocompatibility: Antibody Detection for Risk Assessment and Evaluation of Response to Treatment
Presented by Michelle Hickey, PhD, F(ACHI)
Pathology: Pathologist's Journey — Tasks, Challenges and New Tools
Presented by Fiorella Calabrese, MD
New Biomarker: Molecular Biomarker for Graft Injury (Cell-free DNA) and Humoral Alloreactivity (DSA) for Early Diagnosis of AMR
Presented by Sean Agbor-Enoh, MD, PhD
